| Literature DB >> 34346665 |
Pilar Marcos1, Rafael Coveñas2.
Abstract
Several cholinergic regions have been detected in the brainstem of mammals. In general, these regions are constant among different species, and the nuclear complement is maintained in animals belonging to the same order. The cholinergic system of the brainstem has been partially described in Cetartiodactyla, except for the medulla oblongata. In this work carried out in the alpaca, the description of the cholinergic regions in this order is completed by the immunohistochemical detection of the enzyme choline acetyltransferase (ChAT). In addition, using double immunostaining techniques, the relationship between the cholinergic system and the distribution of calcitonin gene-related peptide (CGRP) previously described is analysed. Although these two substances are found in several brainstem regions, the coexistence in the same cell bodies was observed only in the laterodorsal tegmental nucleus, the nucleus ambiguus and the reticular formation. These results suggest that the interaction between ChAT and CGRP may be important in the regulation of voluntary movements, the control of rapid eye movement sleep and states of wakefulness as well as in reward mechanisms. Comparing the present results with others previously obtained by our group regarding the catecholaminergic system in the alpaca brainstem, it seems that CGRP may be more functionally related to the latter system than to the cholinergic system.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34346665 PMCID: PMC8314389 DOI: 10.4081/ejh.2021.3266
Source DB: PubMed Journal: Eur J Histochem ISSN: 1121-760X Impact factor: 3.188
Figure 1.Mapping of the distribution of CGRP- and ChATimmunoreactive structures in the alpaca brainstem according to the anatomical description carried out by de Souza et al.,[6,7] from rostral (A) to caudal levels (I). For the detailed distribution of structures containing CGRP see de Souza et al.[ Mapping of CGRP is represented on the right side by squares and ChAT-positive structures are represented by dots on the left side, as well as double-labelled cell bodies (red asterisks). Circles show only location and are not reflective of actual numbers of positive neurons. Immunoreactive fibers are represented by continuous short lines. III, nucleus of oculomotor nerve (III cranial nerve); IV, nucleus of the trochlear nerve (IV cranial nerve); Vm, motor trigeminal nerve; VI, abducens nerve (VI cranial nerve); VII, facial nerve (VII cranial nerve); XII, nucleus of the hypoglossal nerve (XII cranial nerve); 5M, motor trigeminal nucleus; 7L, facial nucleus, lateral division; 7M, facial nucleus, medial division; Amb, nucleus ambiguus; BC, brachium conjunctivum; BP, brachium pontis; CAE, locus coeruleus; DMV, motor dorsal nucleus of the vagus nerve; DRM, dorsal nucleus of the raphe; EW. nucleus of Edinger-Westphal; FRet, reticular formation; IO, inferior olive; IP, interpeduncular nucleus; LDT, laterodorsal tegmental nucleus; LRet, lateral reticular nucleus; MLB, medial longitudinal bundle; PAG, periaqueductal gray; PBG, parabigeminal nucleus; PPT, pedunculopontine tegmental nucleus; SC, superior colliculus; SN, substantia nigra.
Figure 2.Photomicrographs showing immunolabeling for CGRP (brown precipitate) and ChAT (blue colour). White arrows point to CGRP-containing neurons, and black arrows point to cholinergic cell bodies. White arrowheads point to double-labelled neurons. The boundaries of each nucleus are delineated by dashed lines. A) CGRP-positive neurons in the nucleus ambiguus (Amb). B) The same region in a brain section adjacent to A, showing double labelling for ChAT and CGRP. C) High-power magnification of the area squared in B. Scarce double-labelled cell bodies (white arrowhead) were detected in the nucleus ambiguus. D) Cholinergic immunostaining observed in the motor trigeminal nucleus (5M) and nerve (Vm), intermingled with CGRP-positive immunolabeling. E) High-power magnification of the area squared in C. Numerous ChAT-immunoreactive cell bodies (black arrows) and scarce neurons containing CGRP (white arrow) can be detected in this nucleus. F) Cell bodies positive for ChAT (black arrows) and CGRP (white arrows) observed in the reticular formation (FRet). Scale bar: 100 μm.
Figure 3.Pictures of different pontomesencephalic regions containing ChAT (blue precipitate) and CGRP (brown). The boundaries of each nucleus are delineated by dashed lines. A) Cell bodies containing CGRP in the laterodorsal tegmental nucleus (LDT). B) Cell bodies containing CGRP (white arrows) detected in the cholinergic LDT; numerous cholinergic cell bodies were observed (black arrows), as well as some neurons containing CGRP and ChAT (white arrowheads). C) High-power magnification of the area squared in B. Cholinergic cell bodies are pointed by black arrows and CGRP-positive neurons by white arrows; double-labelled cell bodies (white arrowheads) were also detected. D) High density, heavily immunostained cholinergic neurons observed in the pedunculopontine nucleus; scarce neurons containing CGRP (white arrows) are observed in this region. E) Noncholinergic CGRP-immunoreactive neurons observed in the locus coeruleus (LC). F) The same region displaying double labelling CGRP/TH (see text); massive coexistence (white arrowheads) can be observed in neurons of the LC for these two substances compared to CGRP/ChAT (E); some single-immunolabeled neurons are also detected (black arrow for TH; white arrow for CGRP). Scale bar: 100 μm.